October 12, Hubei People's Government and China National Pharmaceutical Group signed a strategic cooperation agreement, Medicines Group will invest 50 billion yuan in Hubei development of the pharmaceutical industry.
Under the agreement, National Pharmaceutical Group will invest 50 billion yuan in Hubei to create pharmaceutical R & D and design,digital thermometer pharmaceutical and medical device manufacturing, pharmaceutical distribution and integrated services platform to further enhance the Hubei Pharmaceutical Industry R & D capabilities, independent innovation, clinical thermometer industrial transformation ability and industry aggregation, boosting the city to achieve biological Optics Valley "internationally renowned,clinical thermometer first-class" goal. In addition, the National Pharmaceutical Group, Wuhan will accelerate cooperation in bio-pharmaceutical industry, in the Optics Valley of biological medicine production base in Central City Construction,digital blood pressure monitor radiation, six central provinces.
...